Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1623

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters

Filter Results:

Show Only CME Accredited Sessions

  • +

    P39 - Patient Advocacy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Patient Advocacy
    • +

      P39.01 - Satisfaction with the Lung Cancer Care Pathway. Is it time to Revise the way we Monitor and Assess Patient Experience?

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P39.02 - ‘Making Moments Matter’ – A Lung Cancer Campaign from the Marie Keating Foundation

      00:00 - 00:00  |  Presenting Author(s): Anne Marie Baird

      • Abstract

      Loading...

    • +

      P39.03 - Developing A Collaborative Northern Roadmap for Lung Cancer Care

      00:00 - 00:00  |  Presenting Author(s): Carolyn Roberts

      • Abstract

      Loading...

    • +

      P39.04 - ALK Positive UK: 42% of UK Patients do not Receive Regular Brain MRI Scans Despite Data Showing up to 70% of Patients Develop Brain Metastases

      00:00 - 00:00  |  Presenting Author(s): Debra Montague

      • Abstract

      Loading...

    • +

      P39.05 - Access Disparities and Challenges in Lung Cancer Diagnostics and Treatment – A European Perspective

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P39.06 - Surviving Metastatic Non-Small Cell Lung Cancer – Experience and Supportive Care Needs of Patients Receiving Novel Therapies 

      00:00 - 00:00  |  Presenting Author(s): Sarah Ellen Heynemann

      • Abstract

      Loading...

    • +

      P39.07 - Evaluating the Success of the First Global Lung Cancer Coalition Patient Experience Survey

      00:00 - 00:00  |  Presenting Author(s): Vanessa Beattie

      • Abstract

      Loading...

    • +

      P39.08 - The Effect of COVID-19 on Anxiety in Canadian Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Christina Sit

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      P39.09 - Social Media Support of Lung Cancer Patient Associations During the Lockdown Restrictions in Italy: A Breath of Life During the COVID-19 Pandemic.

      00:00 - 00:00  |  Presenting Author(s): Tindara Franchina

      • Abstract

      Loading...

  • +

    P40 - Risk Reduction and Tobacco Control

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Risk Reduction and Tobacco Control
    • +

      P40.01 - Tobacco use in Adolescence and Associated Factors: Products, School, Family, Peers and Movies in Pandemic Period

      00:00 - 00:00  |  Presenting Author(s): Domenico Galetta

      • Abstract

      Loading...

    • +

      P40.02 - Female Lung Cancer: An Emerging Issue in Bangladesh

      00:00 - 00:00  |  Presenting Author(s): Nausheen Hakim

      • Abstract

      Loading...

    • +

      P40.03 - Report on a Phytochemical-rich Dietary Intervention Trial to Prevent Lung Cancer: Implementation in a High-Risk Lung Screening Clinic

      00:00 - 00:00  |  Presenting Author(s): Marisa Bittoni

      • Abstract

      Loading...

    • +

      P40.04 - Knowledge, Attitudes and Perception of Lung Cancer Screening Among Smoking Soft-Ware Professionals in India

      00:00 - 00:00  |  Presenting Author(s): Venkata pradeep babu Koyyala

      • Abstract

      Loading...

    • +

      P40.05 - Current Status of a Smoking Cessation Supportive Program on Nurses' Interventions: A Single Institutional Experience

      00:00 - 00:00  |  Presenting Author(s): Reiko Kori

      • Abstract

      Loading...

  • +

    P41 - Screening and Early Detection - Lung Cancer Screening Programmes

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P41.01 - Disparities in Lung Cancer Screening by Baseline Comorbidities:  An Analysis of the Behavioral Risk Factor Surveillance System Survey 2018

      00:00 - 00:00  |  Presenting Author(s): Qian Wang

      • Abstract

      Loading...

    • +

      P41.02 - Implementation Barriers In US-based Lung Cancer Screening Programs

      00:00 - 00:00  |  Presenting Author(s): Andrew Ciupek

      • Abstract

      Loading...

    • +

      P41.03 - Long-Term Results of Screening-Detected Lung Cancer in the Polish Cohort. 

      00:00 - 00:00  |  Presenting Author(s): Robert Dziedzic

      • Abstract

      Loading...

    • +

      P41.04 - The SUMMIT Study: Pulmonary Nodule and Incidental Findings in the First 10,000 Participants of a Population-Based Low-Dose CT Screening Study

      00:00 - 00:00  |  Presenting Author(s): Jennifer L Dickson

      • Abstract

      Loading...

    • +

      P41.05 - Challenges of Implementing Lung Cancer Screening in Brazil: Preliminary Results of a Multicenter Group

      00:00 - 00:00  |  Presenting Author(s): Ricardo Santos

      • Abstract

      Loading...

    • +

      P41.06 - As Seen from the Rearview Mirror: A Retrospective Analysis of Lung Cancer Screening in Patients with Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Coral Olazagasti

      • Abstract

      Loading...

    • +

      P41.07 - Lung Cancer Screening: What is the State of the Evidence about Implementation?

      00:00 - 00:00  |  Presenting Author(s): Nicole Rankin

      • Abstract

      Loading...

    • +

      P41.08 - Using Autoregressive Integrated Moving Average (ARIMA) Modeling to Quantify the Impact of USPSTF Lung Cancer Screening Guidelines

      00:00 - 00:00  |  Presenting Author(s): Leah Elson

      • Abstract

      Loading...

    • +

      P41.09 - Comorbidity Profile and Diagnostic Complication Risk: A Study of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

      00:00 - 00:00  |  Presenting Author(s): Eric M Robinson

      • Abstract

      Loading...

    • +

      P41.10 - Initial Low Dose CT for Lung Cancer Screening and Recalls at Kaiser Permanente Mid-Atlantic States

      00:00 - 00:00  |  Presenting Author(s): Monica Ter-Minassian

      • Abstract

      Loading...

  • +

    P42 - Screening and Early Detection - Risk Modelling and Artificial Intelligence

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P42.01 - AI Assistance for Pulmonary Nodule Stratification: An Multiple-Reader Multiple-Case Study

      00:00 - 00:00  |  Presenting Author(s): Emma O'Dowd

      • Abstract

      Loading...

    • +

      P42.02 - Evaluating the Feasibility of a Deep Learning-Based Computer-Aided Detection System for Lung Nodule Detection in a Lung Cancer Screening Program

      00:00 - 00:00  |  Presenting Author(s): Sunyi Zheng

      • Abstract

      Loading...

    • +

      P42.03 - A Dynamic Deep Learning Approach to Predict Clinical Outcomes of Patients with Advanced Non-Small Cell Lung Cancer under Nivolumab Monotherapy

      00:00 - 00:00  |  Presenting Author(s): Shun Lu

      • Abstract

      Loading...

    • +

      P42.04 - Is AI Better for Prediction of Pathologial Subtype in Pulmonary Nodules? 

      00:00 - 00:00  |  Presenting Author(s): shuaibo Wang

      • Abstract

      Loading...

    • +

      P42.05 - Investigating the Accuracy of Clinical Mathematical Models for Estimating the Probability of Malignancy in Patients With Pulmonary Nodules

      00:00 - 00:00  |  Presenting Author(s): Kevin Zhang

      • Abstract

      Loading...

    • +

      P42.06 - Automatic Lung Nodule Detection by a Deep Learning-Based CAD System: The Value of Slab Thickness in the Maximum Intensity Projection Technique

      00:00 - 00:00  |  Presenting Author(s): Sunyi Zheng

      • Abstract

      Loading...

    • +

      P42.07 - Comparative Performance of Lung Cancer Risk Models to Define Lung Screening Eligibility in the United Kingdom

      00:00 - 00:00  |  Presenting Author(s): Hilary A Robbins

      • Abstract

      Loading...

    • +

      P42.08 - Association Between the Age at First-Live Birth and Lung Cancer Risk: Meta-Analysis and Mendelian Randomization Analysis

      00:00 - 00:00  |  Presenting Author(s): Yiyuan Ao

      • Abstract

      Loading...

    • +

      P42.09 - Predicting Malignancy of Pulmonary Subsolid Nodules on CT Images: Combining Radiologist Diagnosis and Convolutional Neural Network

      00:00 - 00:00  |  Presenting Author(s): Tianle Shen

      • Abstract

      Loading...

  • +

    P43 - Screening and Early Detection - Biomarkers

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P43.01 - Utility of Sputum for Non-Invasive Assessment of Lung Cancer Risk with the LuCED® Test: Specimen Satisfactory Rate

      00:00 - 00:00  |  Presenting Author(s): Michael Meyer

      • Abstract

      Loading...

    • +

      P43.02 - A Multiplex Plasma Protein Panel for Detection of Lung Cancer in Ever Smokers Not Currently Eligible for Screening

      00:00 - 00:00  |  Presenting Author(s): Stephen Lam

      • Abstract

      Loading...

    • +

      P43.03 - Sphingomyelin Is a Candidate Predictor for Lung Adenocarcinoma Recurrence After Radical Surgery

      00:00 - 00:00  |  Presenting Author(s): Yusuke Takanashi

      • Abstract

      Loading...

    • +

      P43.04 - Efficient Isolation and Quantification of CTC in NSCLC Patients using Peptide-Functionalized Magnetic Nanoparticles

      00:00 - 00:00  |  Presenting Author(s): Naixin Liang

      • Abstract

      Loading...

    • +

      P43.05 - No Causal Association is Found Between C-Reactive Protein and Lung Cancer Risk: A Mendelian Randomization

      00:00 - 00:00  |  Presenting Author(s): Jiana Chen

      • Abstract

      Loading...

  • +

    P44 - Screening and Early Detection - Association of Lung Cancer with other Chronic Diseases

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P44.01 - Menstruation and Lung Cancer Risk: A Meta-Analysis and a Mendelian Randomization Study

      00:00 - 00:00  |  Presenting Author(s): Runchen Wang

      • Abstract

      Loading...

    • +

      P44.02 - Mild Interstitial Pneumonia as a Risk Factor for Chemotherapy-Induced Acute Exacerbation of Interstitial Pneumonia in Patients with Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Takashi Umeda

      • Abstract

      Loading...

    • +

      P44.03 - Combined Aortic Valve and Coronary Artery Calcifications in Lung Cancer Screening as Predictors of Death from Cardiovascular Disease

      00:00 - 00:00  |  Presenting Author(s): Yeqing Zhu

      • Abstract

      Loading...

    • +

      P44.04 - Evaluating Lung Cancer Screening in People Living With HIV

      00:00 - 00:00  |  Presenting Author(s): Shawn Jindal

      • Abstract

      Loading...

    • +

      P44.05 - Bone Density Measures Out-Perform Clinical Risk Scores in Detection of Vertebral Fractures in a Lung Cancer Screening Cohort

      00:00 - 00:00  |  Presenting Author(s): Nikita Patel

      • Abstract

      Loading...

  • +

    P45 - Screening and Early Detection - Radiological Risk Stratification

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P45.01 - Lung Cancer Probability and Clinical Outcomes of Baseline and New Ground-Glass Opacity Nodules Detected on Low-Dose CT Screening

      00:00 - 00:00  |  Presenting Author(s): Yeon Wook Kim

      • Abstract

      Loading...

    • +

      P45.02 - Regional Emphysema Score Is Associated With Tumor Location and Poor Prognosis in Completely Resected NSCLC Patients

      00:00 - 00:00  |  Presenting Author(s): Chang Dong Yeo

      • Abstract

      Loading...

    • +

      P45.03 - Lung Nodule Management Based on Diameter and Volume in Lung Cancer Screening with Low-Dose Computed Tomography

      00:00 - 00:00  |  Presenting Author(s): Yihui Du

      • Abstract

      Loading...

    • +

      P45.04 - Radiologic and Clinical Features of Screening-Detected Pulmonary Invasive Mucinous Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Dae Hyeon Kim

      • Abstract

      Loading...

    • +

      P45.05 - Two Distinguished Subtypes of Part-Solid Lung Adenocarcinomas: Radiologic-Clinicopathologic Features and Prognosis

      00:00 - 00:00  |  Presenting Author(s): Jinglei Lai

      • Abstract

      Loading...

  • +

    P46 - Screening and Early Detection - Gene-Based Risk Stratification

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P46.01 - Intronic Noncoding RNA Expression of DCN is Related to Cancer-Associated Fibroblasts and NSCLC Patients’ Prognosis

      00:00 - 00:00  |  Presenting Author(s): Jian Zhou

      • Abstract

      Loading...

    • +

      P46.02 - Correlation of Monitoring ctDNA EGFRm using R-SuperARMS with Clinical Outcomes in Patients with Advanced Lung Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Jiuwei Cui

      • Abstract

      Loading...

    • +

      P46.03 - DNA Methylation Analysis in Smokers and Non-Smokers (Passive and ex-Smokers)

      00:00 - 00:00  |  Presenting Author(s): Diana Monserrat Aguilar-Beltrán

      • Abstract

      Loading...

    • +

      P46.04 - Identify Lung Adenocarcinoma among Pulmonary Micro-nodules through Blood Gene Expression Profiles

      00:00 - 00:00  |  Presenting Author(s): Baohui Han

      • Abstract

      Loading...

    • +

      P46.05 - A Blood Six-Gene Test for Early-Stage Lung Adenocarcinoma Screening in Asympomatic Population

      00:00 - 00:00  |  Presenting Author(s): Baohui Han

      • Abstract

      Loading...

    • +

      P46.06 - Cell-Free DNA (cfDNA) Methylation Assay Allows for Early Detection and Identification of Lung Cancer 

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P46.07 - An Extended Targeted RNA Sequencing for Fusion Detection with Oncomine Comprehensive Assay Plus

      00:00 - 00:00  |  Presenting Author(s): Alex View Hune Teoh

      • Abstract

      Loading...

  • +

    P47 - Small Cell Lung Cancer/NET - Biology / Translational

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Small Cell Lung Cancer/NET
    • +

      P47.01 - Plasma Exosomal Long RNA in SCLC Diagnosis and Prognosis

      00:00 - 00:00  |  Presenting Author(s): Chang Liu

      • Abstract

      Loading...

    • +

      P47.02 - CCL19 Associates with Inferior Prognosis in Patients with SCLC Through Promoting Invasion and Metastasis

      00:00 - 00:00  |  Presenting Author(s): qian Liu

      • Abstract

      Loading...

    • +

      P47.03 - Understanding Lung Neuroendocrine Tumor Progression Combining Organoid Models and Multi-Omic Analyses

      00:00 - 00:00  |  Presenting Author(s): Nicolas Alcala

      • Abstract

      Loading...

    • +

      P47.04 - Neuroendocrine Transformation from EGFR-wild type or TKI-naïve Non-Small Cell Lung Cancer: An Under-Recognized Phenomenon?

      00:00 - 00:00  |  Presenting Author(s): Xiao Chu

      • Abstract

      Loading...

    • +

      P47.05 - Clinicopathological Analysis on 247 Cases of Resected Limited Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Li Liu

      • Abstract

      Loading...

    • +

      P47.06 - Delta-Radiomics Features for Assessment of Individualized Therapeutic Response in Small Cell Lung Cancer – A Pilot Study

      00:00 - 00:00  |  Presenting Author(s): jose Arimateia Batista Araujo Filho

      • Abstract

      Loading...

    • +

      P47.07 - Exploration of Aberrant Methylation Patterns in the Chemotherapy Insensitivity of Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Peixin Chen

      • Abstract

      Loading...

    • +

      P47.08 - Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Clinical Benefit of Immunotherapy in Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Xingsheng Hu

      • Abstract

      Loading...

    • +

      P47.09 - Quantification and Classification of Tumor Infiltrating Leukocytes (TILs) and its Impact on Prognosis in Small Cell Lung Cancer (SCLC)  

      00:00 - 00:00  |  Presenting Author(s): Yiying Guo

      • Abstract

      Loading...

    • +

      P47.10 - Predicting ROR1/BCL2 Combination Targeted Therapy of Small Cell Carcinoma of the Lung

      00:00 - 00:00  |  Presenting Author(s): Walter Wang

      • Abstract

      Loading...

    • +

      P47.11 - DLL-3 and ASCL-1 Expression Emerge as Promising Therapeutic Targets in High-Grade Neuroendocrine Lung Tumors: A Preliminary Study

      00:00 - 00:00  |  Presenting Author(s): Tabatha Gutierrez Prieto

      • Abstract

      Loading...

    • +

      P47.12 - Does Pulmonary Adenocarcinoma With Neuroendocrine Differentiation Deserve A New Classification?

      00:00 - 00:00  |  Presenting Author(s): JIAXI He

      • Abstract

      Loading...

    • +

      P47.13 - Galectin-9, A Novel Prognostic Factor in Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Peixin Chen

      • Abstract

      Loading...

    • +

      P47.14 - Clinicopathologic Features of Large Cell Neuroendocrine Carcinoma of Lung

      00:00 - 00:00  |  Presenting Author(s): Perran Fulden Yumuk

      • Abstract

      Loading...

    • +

      P47.15 - Mutational Landscape of Homologous Recombination Pathway in Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Xin Li

      • Abstract

      Loading...

  • +

    P48 - Small Cell Lung Cancer/NET - Chemo - IO

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Small Cell Lung Cancer/NET
    • +

      P48.01 - Gemcitabine and Nivolumab for Subsequent Treatment of Metastatic Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Thomas William Lycan

      • Abstract

      Loading...

    • +

      P48.02 - NRG Oncology/Alliance LU005: Chemoradiation vs. Chemoradiation Plus Atezolizumab in Limited Stage Small Cell Lung Cancer 

      00:00 - 00:00  |  Presenting Author(s): Kristin A. Higgins

      • Abstract

      Loading...

    • +

      P48.03 - First-Line Durvalumab plus Platinum-Etoposide in ES-SCLC: Exploratory Analyses Based on Extent of Disease in CASPIAN

      00:00 - 00:00  |  Presenting Author(s): Niels Reinmuth

      • Abstract

      Loading...

    • +

      P48.04 - IMfirst; Phase IIIB Safety Study of Atezolizumab Plus Chemotherapy in a Real World Population of Untreated ES-SCLC

      00:00 - 00:00  |  Presenting Author(s): Rosario Garcia Campelo

      • Abstract

      Loading...

    • +

      P48.05 - Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial

      00:00 - 00:00  |  Presenting Author(s): Peng-Bo Deng

      • Abstract

      Loading...

    • +

      P48.06 - Lurbinectedin in Combination with Pembrolizumab for Patients with Relapsed Small Cell Lung Cancer. LUPER Clinical Trial

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P48.07 - Synergistic Antitumor Effects of Anlotinib Combination With Oral 5-Fluorouracil S-1 in Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Haihua Yang

      • Abstract

      Loading...

    • +

      P48.08 - Phase IV Clinical Study on the Safety and Efficacy of Lobaplatin-Based Regimen With Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Ying Cheng

      • Abstract

      Loading...

    • +

      P48.09 - Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial

      00:00 - 00:00  |  Presenting Author(s): Baohui Han

      • Abstract

      Loading...

    • +

      P48.10 - Chemo-Immunotherapy in the Frontline of Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Indirect Comparisons

      00:00 - 00:00  |  Presenting Author(s): Antonio Galvano

      • Abstract

      Loading...

    • +

      P48.11 - Anlotinib Versus Chemotherapy as a Third-Line or Further Treatment for Advanced Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Yue Wang

      • Abstract

      Loading...

    • +

      P48.12 - A Meta-Analysis of ICI +EP vs. EP  for  Untreated Extensive SCLC  using  GRADE System Approach for Certainty in the Evidence.

      00:00 - 00:00  |  Presenting Author(s): Carolina Gabay

      • Abstract

      Loading...

    • +

      P48.13 - Immune Checkpoint Inhibitors Combined with Etoposide-Platinum as First-Line Therapy for Extensive-Stage SCLC: A Network Meta-Analysis

      00:00 - 00:00  |  Presenting Author(s): Jiuwei Cui

      • Abstract

      Loading...

    • +

      P48.14 - RESILIENT Part 2: A phase 3 Study of Liposomal Irinotecan in Patients with Small-Cell Lung Cancer in the Second-Line Setting

      00:00 - 00:00  |  Presenting Author(s): Luis Paz-Ares

      • Abstract

      Loading...

    • +

      P48.15 - A Case from a Single-Arm, Phase Two, Open Label Study Assessing Sindilimab Plus Metaformin in Chemotherapy Failed PD-L1 Positive Advanced SCLC

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P48.16 - Network Meta-Analysis  of ICI for Extensive Small-Cell Lung Cancer  (ESCLC) as Upfront Therapy

      00:00 - 00:00  |  Presenting Author(s): Carolina Gabay

      • Abstract

      Loading...

    • +

      P48.17 - Efficacy and Safety of AK104, an Anti‐PD‐1/CTLA‐4 Bispecific Antibody, in a Patient with Large Cell Neuroendocrine Carcinoma of the Lung

      00:00 - 00:00  |  Presenting Author(s): Sophia Frentzas

      • Abstract

      Loading...

    • +

      P48.18 - Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis

      00:00 - 00:00  |  Presenting Author(s): Arani Sathiyapalan

      • Abstract

      Loading...

    • +

      P48.19 - Outcomes of Patients Treated with First Line Immunotherapy Plus Chemotherapy for ES-SCLC: Real World Outcomes from a Tertiary Academic Center

      00:00 - 00:00  |  Presenting Author(s): Sandip H Patel

      • Abstract

      Loading...

    • +

      P48.20 - Trends in Trial Design, Interpretation and Survival in Phase III Clinical Trials on Extensive-Stage SCLC Between 2000 and 2019

      00:00 - 00:00  |  Presenting Author(s): Chia Ching Lee

      • Abstract

      Loading...

    • +

      P48.21 - Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN

      00:00 - 00:00  |  Presenting Author(s): Yanan Zheng

      • Abstract

      Loading...

    • +

      P48.22 - Semi-Mechanistic Models of the Time Course of Neutrophils and Platelets in Cancer Patients Treated With Lurbinectedin

      00:00 - 00:00  |  Presenting Author(s): Salvador Fudio

      • Abstract

      Loading...

    • +

      P48.23 - Exposure-Response Analyses and Clinical Utility Index to Justify the Dosage of Lurbinectedin in Small-cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Salvador Fudio

      • Abstract

      Loading...

    • +

      P48.24 - Anlotinib Combined with Etoposide as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

      00:00 - 00:00  |  Presenting Author(s): Bo Shen

      • Abstract

      Loading...

    • +

      P48.25 - Apatinib Combined with Chemotherapy in First-Line Patients with Extensive-Stage Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jian Shi

      • Abstract

      Loading...